Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Researchers from the Henry and Marilyn Taub Faculty of Computer Science have developed an AI-based method that accelerates ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

CEO Jacob Thaysen leads Illumina's expansion into multiomics beyond DNA sequencing, facing competition from Roche and Chinese ...

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

The Global Synthetic Biology Market is estimated to be valued at USD 13.83 billion in 2023 and is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 17.30% over the forecast period ...

China’s Ministry of Commerce announcement does not mention Illumina’s reagents used in DNA sequencing, the analysts said in a Tuesday note, but the ban on sequencing machines alone could ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Next-generation sequencing (NGS) is a powerful tool to help you and your ... Liquid biopsy examines circulating tumor DNA (ctDNA) that’s shed from dead tumor cells in your bloodstream. The test ...